Skip to main content

Table 1 Length of the window period for test reagents

From: Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010

 

Length of window period (days)

 
 

Estimate

Range

HIV

  

   anti-HIV(EIA)

22*

6~38

   HIV-NAT

11*

 

HCV

  

   anti-HCV(EIA)

66†

38~94

   HCV-NAT

10‡

 

HBV

  

   HBsAg(EIA)

59§

37~87

   HBsAg(CLIA)

45¶

 
  1. *Data were obtained from Busch et al. [3].
  2. †Data were obtained from Courouce et al. [6].
  3. ‡Data were obtained from Dodd et al. [7].
  4. §Data were obtained from Mimms et al. [4].
  5. ¶Data were obtained from Comanor et al. [5].
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us